ASPIRIN AND DIPYRIDAMOLE

Post-LOE

aspirin and dipyridamole

Dr. Reddy's Laboratories
ANDAORALCAPSULE, EXTENDED RELEASE
Approved
Oct 2018
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

Cyclooxygenase Inhibitors

Pharmacologic Class:

Nonsteroidal Anti-inflammatory Drug

Indications (3)

stroke in patientscompleted ischemic stroke due to thrombosiscompleted ischemic stroke due to thrombosis ()
Company
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories
GA - Norcross
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers